Gut microbiota in Parkinson disease in a northern German cohort

Brain Research

Volumn 1667, Issue , 2017, Pages 41-45

  Hopfner, Franziska ^a   Künstner, Axel ^b,c   Müller, Stefanie H ^a   Künzel, Sven ^c   Zeuner, Kirsten E ^a   Margraf, Nils G ^a   Deuschl, Günther ^a   Baines, John F ^a,c   Kuhlenbäumer, Gregor ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

Author keywords

Gut microbiota; Parkinson disease; Stool

Indexed keywords

RNA 16S;

AGED; ARTICLE; BACTEROIDACEAE; BARNESIELLACEAE; BIFIDOBACTERIACEAE; BRADYRHIZOBIACEAE; CHRISTENSENELLACEAE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCACEAE; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLACEAE; MALE; MICROBIAL DIVERSITY; NEXT GENERATION SEQUENCING; NONHUMAN; PARKINSON DISEASE; PASTEURELLACEAE; PREVOTELLACEAE; PRIORITY JOURNAL; RUMINOCOCCACEAE; TISSIERELLACEAE; VERRUCOMICROBIACEAE; AREA UNDER THE CURVE; COHORT ANALYSIS; FECES; GERMANY; MICROBIOLOGY; RECEIVER OPERATING CHARACTERISTIC;

AGED; AREA UNDER CURVE; COHORT STUDIES; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GERMANY; HUMANS; MALE; PARKINSON DISEASE; ROC CURVE;

EID: 85019938845     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2017.04.019     Document Type: Article

References (19)

1. Chaudhuri, K.R., Odin, P., Antonini, A., Martinez-Martin, P., Parkinson's disease: the non-motor issues. Parkinsonism Relat. Disord. 17:10 (2011), 717–723.
2. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13:10 (2012), 701–712.
3. Dickson, D.W., Braak, H., Duda, J.E., et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 8:12 (2009), 1150–1157.
4. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:19 (2010), 2460–2461.
5. Faith, D.P., Conservation evaluation and phylogenetic diversity. Biol. Conserv., 61(1–10), 1992.
6. Hasegawa, S., Goto, S., Tsuji, H., et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease. PLoS One, 10(11), 2015, e0142164.
7. Hawkes, C.H., Del Tredici, K., Braak, H., A timeline for Parkinson's disease. Parkinsonism Relat. Disord. 16:2 (2010), 79–84.
8. Hill-Burns, E.M., Debelius, J.W., Morton, J.T., et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord., 2017.
9. Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55:3 (1992), 181–184.
10. Kalia, L.V., Lang, A.E., Parkinson's disease. Lancet 386:9996 (2015), 896–912.
11. Keshavarzian, A., Green, S.J., Engen, P.A., et al. Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30:10 (2015), 1351–1360.
12. Oksanen J, al. e. vegan: Community Ecology Package. Comprehensive R Archive Network 2011;R package Version 2.2-1.
13. Pringsheim, T., Jette, N., Frolkis, A., Steeves, T.D., The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov. Disord. 29:13 (2014), 1583–1590.
14. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov. Disord. 18:7 (2003), 738–750.
15. Scheperjans, F., Aho, V., Pereira, P.A., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30:3 (2015), 350–358.
16. Schloss, P.D., Westcott, S.L., Ryabin, T., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:23 (2009), 7537–7541.
17. Svensson, E., Horvath-Puho, E., Thomsen, R.W., et al. Vagotomy and subsequent risk of Parkinson's disease. Ann. Neurol. 78:4 (2015), 522–529.
18. Ulusoy, A., Rusconi, R., Perez-Revuelta, B.I., et al. Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol. Med. 5:7 (2013), 1051–1059.
19. Unger, M.M., Spiegel, J., Dillmann, K.U., et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat. Disord. 32 (2016), 66–72.